L Kaklamanis
- Oncology top 5%
- Molecular Biology
- Immunology top 5%
- Pathology and Forensic Medicine top 5%
- Cancer Research top 10%
- Co-authors
- Adrian L. HarrisKevin C. GatterS CottrellWalter F. BodmerD C BicknellRussell LeekP. KorkolopoulouK C Gatter
- Topics
- Monoclonal and Polyclonal Antibodies Research (5 papers)Genetic factors in colorectal cancer (5 papers)Cancer-related Molecular Pathways (4 papers)
- Journals
- The LancetBritish Journal of CancerInternational Journal of Radiation Oncology*Biology*Physics
- Partner nations
- United KingdomGreeceGermany
In The Last Decade
L Kaklamanis
36 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 89
- Oncology 685
- Molecular Biology 542
- Immunology 428
- Pathology and Forensic Medicine 324
- Cancer Research 234
Countries citing papers authored by L Kaklamanis
This map shows the geographic impact of L Kaklamanis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Kaklamanis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Kaklamanis more than expected).
Fields of papers citing papers by L Kaklamanis
This network shows the impact of papers produced by L Kaklamanis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Kaklamanis. The network helps show where L Kaklamanis may publish in the future.
Co-authorship network of co-authors of L Kaklamanis
This figure shows the co-authorship network connecting the top 25 collaborators of L Kaklamanis. A scholar is included among the top collaborators of L Kaklamanis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Kaklamanis. L Kaklamanis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 38 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 93 | |
| 6 | 54 | |
| 7 | 63 | |
| 8 | Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis. | 58 |
| 9 | 6 | |
| 10 | 157 | |
| 11 | 10 | |
| 12 | 71 | |
| 13 | 38 | |
| 14 | 49 | |
| 15 | Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. | 83 |
| 16 | 23 | |
| 17 | p53 expression in colorectal adenomas. | 71 |
| 18 | 191 | |
| 19 | 5 | |
| 20 | 24 |
About L Kaklamanis
L Kaklamanis is a scholar working on Cancer Research, Immunology and Allergy and Oncology, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Genetic factors in colorectal cancer (5 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Oncology (685 citations), Immunology (428 citations) and Pathology and Forensic Medicine (324 citations). L Kaklamanis has collaborated with scholars based in United Kingdom, Greece and Germany. Frequent co-authors include Adrian L. Harris, Kevin C. Gatter, S Cottrell, Walter F. Bodmer, D C Bicknell, Russell Leek, P. Korkolopoulou, K C Gatter, Francesco Pezzella and Michael I. Koukourakis. Their work appears in journals such as The Lancet, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.